Filing Details

Accession Number:
0001144204-14-024307
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-23 16:45:32
Reporting Period:
2014-04-22
Filing Date:
2014-04-23
Accepted Time:
2014-04-23 16:45:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Coronado Biosciences Inc CNDO Pharmaceutical Preparations (2834) 205157386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1510614 Kevin Horgan C/O Coronado Biosciences, Inc.
24 New England Executive Park
Burlington MA US 01803
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-04-22 47,566 $1.71 47,566 No 4 M Direct
Common Stock Disposition 2014-04-22 47,566 $1.89 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2014-04-22 47,566 $0.00 47,566 $1.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-11-05 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.81 to $1.95. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
  2. The vesting of one-third of the shares subject to this option was accelerated upon Dr. Horgan's separation of service from the Issuer.